CLINICAL_TRIALS
trial_result
· 2016-04-11
Clinical Trial Update: Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL) [Phase 2]
Summary
Phase 2 study evaluating Rituximab as maintenance therapy for marginal zone B-cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-A University Hospital | Conditions: Lymphoma | Phase 2 | Status: COMPLETED